"Wiskott-Aldrich Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rare, X-linked immunodeficiency syndrome characterized by ECZEMA; LYMPHOPENIA; and, recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IMMUNOGLOBULIN M levels are low and IMMUNOGLOBULIN A and IMMUNOGLOBULIN E levels are elevated. Lymphoreticular malignancies are common.
| Descriptor ID |
D014923
|
| MeSH Number(s) |
C15.378.100.100.970 C15.378.463.960 C15.378.553.546.605.900 C16.320.099.970 C16.320.322.937 C20.673.627.900
|
| Concept/Terms |
Wiskott-Aldrich Syndrome- Wiskott-Aldrich Syndrome
- Syndrome, Wiskott-Aldrich
- Wiskott Aldrich Syndrome
- Wiskott Syndrome
- Imd2
- Immunodeficiency 2
- Aldrich Syndrome
- Syndrome, Aldrich
- Eczema-Thrombocytopenia-Immunodeficiency Syndrome
- Eczema Thrombocytopenia Immunodeficiency Syndrome
- Eczema-Thrombocytopenia-Immunodeficiency Syndromes
- Syndrome, Eczema-Thrombocytopenia-Immunodeficiency
- Syndromes, Eczema-Thrombocytopenia-Immunodeficiency
|
Below are MeSH descriptors whose meaning is more general than "Wiskott-Aldrich Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Wiskott-Aldrich Syndrome".
This graph shows the total number of publications written about "Wiskott-Aldrich Syndrome" by people in this website by year, and whether "Wiskott-Aldrich Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Wiskott-Aldrich Syndrome" by people in Profiles.
-
Gene therapy for inborn errors of immunity: Current clinical progress. Ann Allergy Asthma Immunol. 2025 Jun; 134(6):630-638.
-
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Blood. 2023 10 12; 142(15):1281-1296.
-
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood. 2020 06 04; 135(23):2094-2105.
-
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome. Biol Blood Marrow Transplant. 2018 03; 24(3):537-541.
-
Successful HLA haploidentical HSCT with post-transplant cyclophosphamide in Wiskott-Aldrich syndrome. Bone Marrow Transplant. 2017 06; 52(6):913-914.
-
50 Years Ago in The Journal of Pediatrics: Wiskott-Aldrich Syndrome: Clinical, Immunologic, and Pathologic Observations. J Pediatr. 2017 02; 181:101.
-
An unusual self-limited clonal Mott cell proliferation with lymphoplasmacytic lymphoma-like features in a child with the Wiskott-Aldrich syndrome and Von Recklinghausen's neurofibromatosis. Pathol Res Pract. 2010 Jul 15; 206(7):467-71.
-
Wiskott-Aldrich syndrome and molluscum contagiosum: a therapeutic challenge after reaction to cidofovir. Int J Dermatol. 2008 Dec; 47(12):1304-5.
-
Long-term follow-up of patients with primary immunodeficiencies. J Allergy Clin Immunol. 2007 Oct; 120(4):795-7.
-
The last 80 years in primary immunodeficiency: how far have we come, how far need we go? J Allergy Clin Immunol. 2006 Apr; 117(4):748-52.